跳至主要内容
临床试验/CTRI/2022/05/042356
CTRI/2022/05/042356尚未招募4 期

Efficacy of Astymin3 as an add on therapy to standard of care in reduction of hospitalizationand improving wound healing in postoperative patients ARandomized single blind controlled clinical trial

Tablets India Limited0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
尚未招募

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Patients elected for open abdominal surgeries such as inguinal hernia surgery
  • Cholecystectomy
  • Appendectomy

排除标准

  • Laparoscopic surgeries
  • Patients with type 1 or type 2 diabetes m
  • Chronic renal failure
  • Acute kidney injury
  • Chronic alcoholic patients
  • Obesity BMI more than 25
  • Any major surgical procedure involving excessive blood loss more than 1 liter
  • CHF and anemia

研究者

相似试验